Maryam Shahhoseini

Dr. Maryam Shahhoseini

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Fertility and Sterility
Verified
Journal Article
Closed access
FEFereshteh Esfandiari
Fereshteh Esfandiari
RFRaha Favaedi
Raha Favaedi
HHHeidar Heidari-Khoei
Heidar Heidari-Khoei
FCFereshteh Chitsazian
Fereshteh Chitsazian
SYSimin Yari
Simin Yari
MSMaryam Shahhoseini
Maryam Shahhoseini

1 December 2021 in Reproductive Biology
Verified
Journal Article
Closed access
FBFateme Olia Bagheri
Fateme Olia Bagheri
AAAliReza Alizadeh
AliReza Alizadeh
MGMohammad Ali Sadighi Gilani
Mohammad Ali Sadighi Gilani
MSMaryam Shahhoseini
Maryam Shahhoseini

8 April 2015
Verified
Journal Article
Open access
KFKhadijeh Falahzadeh
Khadijeh Falahzadeh
M.M.Sc
M.Sc
ABAmir Banaei-Esfahani
Amir Banaei-Esfahani
MSMaryam Shahhoseini
Maryam Shahhoseini
PHPh.D
Ph.D
Over the past few decades, actin's presence in the nucleus has been demonstrated. Actin is a key protein necessary for different nuclear processes. Although actin is well known for its functional role in dynamic behavior of the cytoskeleton, emerging studies are now highlighting new roles for actin. At the present time there is no doubt about the presence of actin in the nucleus. A number of studies have uncovered the functional involvement of actin in nuclear processes. Actin as one of the nuclear components has its own structured and functional rules, such as nuclear matrix association, chromatin remodeling, transcription by RNA polymerases I, II, III and mRNA processing. In this historical review, we attempt to provide an overview of our current understanding of the functions of actin in the nucleus.

1 January 2015 in Fertility and Sterility
Verified
Journal Article
Closed access
SMSoodeh Mahdian
Soodeh Mahdian
RAReza Aflatoonian
Reza Aflatoonian
RYReza Salman Yazdi
Reza Salman Yazdi
PYParichehreh Yaghmaei
Parichehreh Yaghmaei
FRFariba Ramazanali
Fariba Ramazanali
MSMaryam Shahhoseini
Maryam Shahhoseini

27 August 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BNBahar Davoodi Nik
Bahar Davoodi Nik
DKDanial Hashemi Karoii
Danial Hashemi Karoii
RFRaha Favaedi
Raha Favaedi
FRFariba Ramazanali
Fariba Ramazanali
MJMaryam Jahangiri
Maryam Jahangiri
MSMaryam Shahhoseini
Maryam Shahhoseini
Our study probed the differences in ion channel gene expression in the endometrium of women with Recurrent Implantation Failure (RIF) compared to fertile women. We analyzed the relative expression of genes coding for T-type Ca2+, ENaC, CFTR, and KCNQ1 channels in endometrial samples from 20 RIF-affected and 10 control women, aged 22–35, via microarray analysis and quantitative real-time PCR. Additionally, we examined DNA methylation in the regulatory region of KCNQ1 using ChIP real-time PCR. The bioinformatics component of our research included Gene Ontology analysis, protein–protein interaction networks, and signaling pathway mapping to identify key biological processes and pathways implicated in RIF. This led to the discovery of significant alterations in the expression of ion channel genes in RIF women’s endometrium, most notably an overexpression of CFTR and reduced expression of SCNN1A, SCNN1B, SCNN1G, CACNA1H, and KCNQ1. A higher DNA methylation level of KCNQ1’s regulatory region was also observed in RIF patients. Gene-set enrichment analysis highlighted a significant presence of genes involved with ion transport and membrane potential regulation, particularly in sodium and calcium channel complexes, which are vital for cation movement across cell membranes. Genes were also enriched in broader ion channel and transmembrane transporter complexes, underscoring their potential extensive role in cellular ion homeostasis and signaling. These findings suggest a potential involvement of ion channels in the pathology of implantation failure, offering new insights into the mechanisms behind RIF and possible therapeutic targets.

22 April 2022 in Reproductive Health
Verified
Journal Article
Open access
PDF file
SKSedigheh Kamrani
Sedigheh Kamrani
EAElham Amirchaghmaghi
Elham Amirchaghmaghi
FGFirouzeh Ghaffari
Firouzeh Ghaffari
MSMaryam Shahhoseini
Maryam Shahhoseini
KGKamran Ghaedi
Kamran Ghaedi
Background: Endometriosis, as chronic estrogen-dependent disease, is defined by the presence of endometrial-like tissue outside the uterus. Proliferation of endometrial tissue and neoangiogenesis are critical factors in development of endometriosis. Hence, vascular endothelial growth factor (VEGF) as well as insulin‐like growth factor 1 and 2 (IGF1, 2) may be involved as inducers of cellular proliferation or neoangiogenesis. Imprinted long noncoding RNA H19 (lncRNA H19) has been suggested to be involved in pathogenesis of endometriosis via regulation of cellular proliferation and differentiation. Epigenetic aberrations appear to play an important role in its pathogenesis. The present study was designed to elucidate VEGF, IGF1, IGF2 and H19 lncRNA genes expression and epigenetic alterations of differentially methylated region (DMR) of H19 (H19-DMR) regulatory region in endometrial tissues of patients with endometriosis, in comparison with control women. Methods: In this case–control study, 24 women with and without endometriosis were studied for the relative expression of VEGF, IGF1, IGF2 and H19 lncRNA genes using real-time polymerase chain reaction (PCR) technique. Occupancy of the MeCP2 on DMR region of H19 gene was assessed using chromatin immunoprecipitation (ChIP), followed by real-time PCR. Results: Genes expression profile of H19, IGF1 and IGF2 was decreased in eutopic and ectopic endometrial tissues of endometriosis group, compared to the control tissues. Decreased expression of H19 in ectopic samples was significant in comparison with the controls (P < 0.05). Gene expression of VEGF was increased in eutopic tissues of endometriosis group, compared to control group. Whereas its expression level was lower in ectopic lesions versus eutopic and control endometrial samples. ChIP analysis revealed significant and nearly significant hypomethylation of H19-DMR region II in eutopic and ectopic samples, compared to the control group respectively. This epigenetic change was aligned with expression of IGF2. While methylation of H19-DMR region I was not significantly different between the eutopic, ectopic and control endometrial samples. Conclusion: These data showed that VEGF, IGF1, IGF2 and H19 lncRNA genes expression and epigenetic alterations of H19 lncRNA have dynamic role in the pathogenesis of endometriosis, specifically in the way that hypomethylation of H19-DMR region II can be involved in IGF2 dysregulation in endometriosis.